🏢 Brand Settlements
Sanofi, GSK, Boehringer Ingelheim, Pfizer Class Action Settlements — 1 Active Case
SettlementRadar is not affiliated with, endorsed by, or connected to Sanofi, GSK, Boehringer Ingelheim, Pfizer. This page provides independent information about class action settlements involving this company.
0 no-proof settlements — file with no documentation required. Deadlines are approaching. Check eligibility now.
⚖️
1
Active Cases
✅
0
No Proof Required
📅
273d
Nearest Deadline
Open Sanofi, GSK, Boehringer Ingelheim, Pfizer Settlements
Health & Safety
⏳ 273 days left
Zantac (Ranitidine) Cancer Settlement
Manufacturers of Zantac heartburn medication face claims that the drug contained NDMA, a probable human carcinogen, and failed to warn consumers about cancer risks.
Who qualifies: Individuals who regularly took Zantac (ranitidine) and were later diagnosed with cancer, particularly bladder, stomach, liver, esophageal, or pancreat…
$50,000 – $300M
Est. payout per person
⚖️ Legal Information
Case Number: 9:20-md-02924-RLR
Court: U.S. District Court, Southern District of Florida
Settlement Administrator: MDL Settlement Administrator
